Aug. 2, 2012
/PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in
, today announced that it plans to release its second quarter of year 2012 financial results before the market opens on
Wednesday, August 15, 2012
The Company will hold a conference call at
8:30 am ET
August 15, 2012
to discuss second quarter of year 2012 results. Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for international callers, Conference ID # 16312392. A webcast will also be available through CPHI's website at
. A replay of the call will be accessible through
August 23, 2012
by dialing 1-866-214-5335 or 61-282-355-000 for international callers, Conference ID # 16312392.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in
, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in
. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in
, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit